By inhibiting NF-κB signaling, AMPK reduces pro-inflammatory cytokine production (e.g., TNF-α, IL-6), as seen in obesity and diabetes models (13, 19). The gene discussed is NFKB1; the disease is obesity due to melanocortin 4 receptor deficiency.